exam #1 study guide Flashcards

1
Q

what does dyspnea mean

A

shortness of breath perceived by patient

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what does orthopnea mean

A

difficulty breathing in supine position (flat on back)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

ABG interpretation

A

PH- acidosis < 7.35 > alkalosis
CO2- alkalotic <35-45> acidotic
HCO3 acidotic <22-28>
alkalosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what does the sputum color black indicate?

A

smoke or coal dust

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what does the sputum color brown indicate?

A

cigarette smoker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what does the sputum color frothy white/pink indicate

A

pulmonary edema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is overcorrected hypoxemia on O2

A

> 100mmhg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is corrected hypoxemia on O2

A

<100-60mmhg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is severe hypoxemia on O2

A

<60mmhg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

mild hypoxemia ranges

A

60-79mmhg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

moderate hypoxemia ranges

A

40-59mmhg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

severe hypoxemia range

A

<40mmhg severe hypoxemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is type II respiratory failure, its associated names and symptoms

A

alveolar ventilation which is inadequate for the patients current metabolic rate
associated names- hypercapnic/ventilatory
symptoms- loss of consciousness and headache

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is the relationship between alveolar ventilation and PaCO2

A

VA and PaCO2 are inversely proportional
increased VA= decreased PaCO2
decreased VA= increased PaCO2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what does an ABG look like for acute respiratory failure

A

low PaO2 and CaO2, a high PaCO2 with acidotic PH, and an increased RBC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is the treatment for acute asthma attack treatment

A
  1. oxygen
    2.fast acting bronchodilators
    3.svn
  2. continuous bronchodilator therapy
  3. IV/PO corticosteroids
  4. monitor peak flow
  5. IV ketamine
    8.IV magnesium sulfate
  6. heliox therapy
  7. NIPPV
  8. mechanical ventilation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what does the PaCO2 in the different phases of asthma attack

A

Early asthmatic response- hypocapnia (low CO2)
late asthma response- normal PaCO2 indicates more severe obstructive
Hypercapnia is seen with impending respiratory failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what is the main anatomic alteration seen in asthma?

A

airway inflammation, airway hyper-responsiveness, expiratory flow limitations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what is the definition of inspection (and what are you looking for while inspecting)?

A

Inspection involves assessment of the patients overall appearance.
1. look for level of consciousness
2. body habitus (general ill health)
3. position
4. respiratory rate
5. breathing pattern
6. speech pattern
7. skin
8. facial expression
9. personal hygiene
10. sensorium (mental health)
11. nose (nose flaring?)
12. lips (cyanosis or pursed lip breathing)
13. jugular veins (distended?)
14. trachea (midline?)
15. thorax (barrel chest indicating COPD?)
16. digits (digital clubbing?)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what is the definition of palpation?

A

applies the sensation of touch to evaluate underlying structure and function. palpation is performed to assess
1. tracheal position
2. evaluation vocal/tactile fremitus
3. estimate thoracic expansion
4. asses the skin and tissues of the chest and extremities
5. identify abdominal distention and tenderness
6. locate the hearts apical impulse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

what is the definition of percussion?

A

involves tapping the body surface to evaluate the underlying structure, it produces a sound and a palpable vibration useful in evaluating underlying tissue and the position of the diaphragm and liver.
hyperresonant/hyporesonant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

what is the definition of vocal fremitus?

A

it refers to the vibrations created by the vocal cords during speech. These vibrations are transmitted down the tracheobronchial tree and to the chest wall.
increased vocal fremitus occurs when tissue is more solid (pneumonia, lung consolidation)
decreased fremitus- occurs when something is blocking the transmission of sound (pleural effusion, pneumothorax, copd)

23
Q

what is the definition of bradypnea?

A

a breathing rate less than normal

24
Q

what is the definition of Cheyenne-stokes breathing?

A

deep rapid breaths followed by apnea, breaths gradually increase and then gradually decrease until apnea period. (indication of CHF and stroke)

25
Q

what are the conditions associated with increased resonance?

A

COPD, Pneumothorax (heard in the presence of excessive air)

26
Q

what are the indications of pleural effusion (TD, PALP, PERC, BS)

A

tracheal deviation- shifted away from the affected area (push)
palpation- decrease in vibrations (decreased fremitus)
percussion_ hyporesonant dull sound associated with increased density
Breath sounds- diminished or absent due to fluid accumulation preventing lung expansion and sound transmission

27
Q

what are the normal and abnormal percussion notes and there causes?

A

Resonant- are normal percussion notes, clear, low-pitches and hollow quality like the sound of tapping on a drum.
Hyperresonant- are louder and lower pitched heard in the presence of excessive air seen in patients with COPD and pneumothorax.(tympanic)
Hyporesonant- dull sound associated with increased density, seen in patients with pneumonia, atelectasis, and pleural effusion. (flat)

28
Q

what are the causes of tracheal deviation (shifting)

A

tracheal deviation shifts away from the affected area (Push) seen in pneumothorax, and pleural effusion patients.
tracheal deviation shifts towards the affected area (pull) seen in atelectasis and fibrosis patients

29
Q

what does retractions indicate?

A

Indicates inward sinking on or around the chest all and occur due to increased WOB.
(intercostal, subcostal, and substernal/suprasternal effected)

30
Q

what causes unilateral lung expansion and what is it

A

occurs when one lung expands more than the other, it can be caused by pneumonia, pneumothorax, and rib fractures)

31
Q

what are the two chest cavity abnormalities

A

Pectus carinatum- outward sternal profusion(pigeon breast)
pectus excavatum- funnel shaped depression over the sternum (funnel chest)

32
Q

what are all the indicating factors of a pneumothorax

A

chest inspection- unequal/unilateral expansion may be a sign of pneumothorax
tracheal deviation- shifts away from the affected area (push)
chest palpitations- decreased fremitus (decrease in vibrations)
crepitus- subcutaneous emphysema (small gas bubbles under the skin, feels like crackling when palpated)
hyperresonant- lower pitch heard in the presence of excessive air

33
Q

what are the 2 diseases that make up COPD

A

emphysema and chronic bronchitis

34
Q

what are the PFT findings in patients with COPD

A

They have increased residual volumes, total lung capacity, and functional residual capacity
They have decreased values for peak expiratory flow rate, forced vital capacity and forced expiratory volume in 1 second(FEV1)
FEV1/FVC <0.7 confirms the presence of non-reversible airflow obstruction

35
Q

how do you calculate pack years?

A

years smoking X number of packs/day= pack yers
EX: 30 years X 2 1/2 packs/day = 75 pack years

36
Q

what is the pathophysiology of emphysema?

A

emphysema- condition that is characterized by abnormal, permanent enlargement of the alveoli and destruction of the alveolar walls.
1. dilation and destruction of lung parenchyma
2. tissue destruction decreasing surface area of alveoli
3.terminal bronchioles lose elastic fibers and collapse during exhalation
4. results in air trapping and poor gas exchange

37
Q

what is pathophysiology of chronic bronchitis

A

chronic bronchitis- condition that is characterized by a chronic productive cough for at least 3 months/year for at least 2 consecutive years
1. inflammation leds to mucus glands growing larger, which leads to increased ,mucus production
2. excessive mucus production and inflammation in smaller airways impairs airflow to alveoli

38
Q

what are the X-Ray findings in patients with COPD

A
  1. hyperinflation
  2. flattened diaphragm
  3. elongated (vertical) heart
  4. Bullae (blebs)- air that filled spaces within the lung parenchyma that form because of the destruction of alveolar tissue
39
Q

what is the treatment for Alpha 1 anti-trypsin deficiency?

A

given Prolastin (alpha 1-proteinase inhibitor-human) given by IV and weekly administered (for life) associated with slowed rate of decline of lung function and improved survival

40
Q

what are the COPD symptoms upon inspection?

A
  1. barrel chest
  2. accessory muscle use
  3. tri-pod position
  4. cyanosis
  5. digital clubbing
  6. dyspnea
  7. JVD (sign of HF)
41
Q

what are the COPD symptoms upon palpation

A
  1. decreased fremitus
  2. decreased chest expansion
42
Q

COPD symptom upon percussion

A

hyperresonance

43
Q

COPD symptoms upon auscultation

A
  1. decreased breath sounds with prolonged expiration due to reduced airflow
  2. wheezing can occur due to bronchospasm
  3. coarse crackles/rhonchi can occur when secretions are present
44
Q

COPD symptoms related to cough

A
  1. frequent, productive cough
  2. alteration in color is indicative of infection
45
Q

COPD symptoms in relation to ABG’s

A
  1. acute ventilatory/hypoxemic failure
  2. chronic ventilatory/hypoxemic failure
  3. acute on chronic respiratory failure
46
Q

COPD symptoms related to labs (CBC)

A

increased RBC, HB, HCT due to chronic hypoxemia
WBC is increased when infection/fever present

47
Q

what is the etiology of COPD

A
  1. smoking- 80-90% of COPD related deaths
  2. environmental/occupational exposures (air pollution, biomass fuels, ad chemicals)
  3. genetic- Alpha-1 antitrypsin deficiency
48
Q

what are the effects of cigarettes

A

80-90% of COPD related deaths, cigarette smoking kills more than 480,000 Americans each year

49
Q

what is the treatment for acute exacerbations?

A
  • Inhaled bronchodilators
    SABA: Albuterol
    SAMA: Ipratropium bromide
  • Inhaled steroids
    Budesonide
  • IV steroids
    Solu-medrol
  • Antibiotics
    If infection is suspected
  • Oxygen therapy
    Nasal cannula (most used)
    Maintain SpO2 that is appropriate for individual patient
  • NIPPV
    Has shown to decrease morbidity and mortality
    Intubation and mechanical ventilation
  • Secretion mobilization
    Chest physiotherapy (CPT) or postural drainage and percussion (PD&P)
    Vibratory PEP or HFCWO therapy
50
Q

how is COPD classified?

A
  • Patients can be categorized by severity of symptoms and frequency of exacerbations
  • COPD assessment test (CAT) score or mMRC dyspnea scale can be used to assess symptom severity
    *Scored ABCD- class A is less symptomatic and 0-1 exacerbations a year
    Class B- frequent symptoms but not a lot of exacerbations
    Class C- greater or equal to 2 exacerbations a year but less daily symptoms (unicorn)
    Class D-two or more exacerbations a year and high symptom burdens
51
Q

COPD treatment based on classification
ACUTE TREATMENT

A
  • Inhaled bronchodilators
    SABA: Albuterol
    SAMA: Ipratropium bromide
  • Inhaled steroids
    Budesonide
  • IV steroids
    Solu-medrol
  • Antibiotics
    If infection is suspected
  • Oxygen therapy
    Nasal cannula (most used)
    Maintain SpO2 that is appropriate for individual patient
  • NIPPV
    Has shown to decrease morbidity and mortality
    Intubation and mechanical ventilation
  • Secretion mobilization
    Chest physiotherapy (CPT) or postural drainage and percussion (PD&P)
    Vibratory PEP or HFCWO therapy
52
Q

COPD treatment based on classification
CHRONIC MANAGEMENT

A
  • Inhaled bronchodilators
    LABA: formoterol
    LAMA: tiotropium
    Variety of combo inhalers available
  • Inhaled steroids
    Budesonide, fluticasone
    Variety of combo inhalers available
  • Vaccination
    Influenza, pneumococcal, covid-19, pertussis
    Helps prevent secondary infections
  • Oxygen therapy
    Long term administration in patients with severe hypoxemia has shown to increase survival rates
  • NIPPV or CPAP
    Home use of NIPPV has been shown to decrease hospital readmissions for exacerbations
    CPAP may be preferred in patients with known obstructive sleep apnea
  • Pulmonary rehab
    Exercise training
    Education
    Managing symptoms
    Typically, 6-8 weeks in length
    Associated with significant reduction in hospital length of stay
  • Prevention
    Identifying and reducing exposure to risk factors
    Smoking cessation
    Avoid exposure to occupation irritants
    Avoid exposure to environmental irritants
53
Q

COPD based on classification
ADVANCED TREATMENT

A
  • Lung volume reduction surgery
    Areas of the lung with the most hyperinflation are resected
    Improves lung mechanics of remaining tissue
    Higher mortality rates are associated in patients with severe emphysema
  • Endobronchial valves
    Less invasive approach to lung reduction
    Valve opens during exhalation and allows air to escape
    During inhalation, the valves close and prevents air from entering the treated lobe
    Patients tend to have lower number of exacerbations post treatment
  • Lung transplantation
    Considered for patients who are not candidates for LVRS
    Very severe COPD patients (FEV1 <20%)
    Limited availability due to cost and shortage of donor organs